Relative to its peers, OGEN does not have very much institutional sponsorship. The 14.08% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 78.1 Thousand shares of Oragenics Inc
GEODE CAPITAL MANAGEMENT LLC Bought 52.0 Thousand shares of Oragenics Inc
JANNEY MONTGOMERY SCOTT LLC (INV... Bought 37.9 Thousand shares of Oragenics Inc